New research by the Medicines and Healthcare products Regulatory Agency (MHRA) in partnership with the GSK Vaccines Institute ...

The VENTANA BAP1 (SP527) test helps confidently distinguish malignant mesothelioma from lung, breast and stomach cancers, as well as benign tissue growth in the chest or abdomen.

Cloud-Clone Copeptin ELISA kits deliver critical quantitative evidence supporting the landmark neuroendocrine crosstalk ...

A proposed test for mirror life would read the handedness of living cells by the way they glow, using the same property of ...

A peer-reviewed study of 230 human clinical samples found that a CRISPR-assisted nanodroplet assay identified NTM species and ...

AnteoTech (ASX:ADO) is classified by the Australian Securities Exchange as a materials company but part of its offering sits ...

A new review finds that biosensors built from insect olfactory receptors, odorant-binding proteins, and enzymes show strong ...

The next major breakthrough in life sciences may have a company’s name attached to it, but increasingly, the story behind ...

Roche announced that it has received the CE Mark for its cobas smart e immunoanalyser, a compact, standalone platform engineered to deliver reliable testing with a planned menu of over 100 ...

Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the third quarter ended September 30, 2026. Third ...

Revolune today announced a partnership with Concept Life Sciences to help biopharma and life sciences customers reassess, transfer, and ...

SEKISUI Diagnostics, a global medical diagnostics manufacturer, has announced the launch of a 510(k) cleared rapid test to detect COVID-19 and Flu A&B in professional healthcare settings.